Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Jun 27, 2026
Brookdale Senior Living Inc. (BKD)
A forensic read on Brookdale Senior Living Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
F · Poor — capital at risk
Forensic grade
Distress
Financial health
-2.4
Altman Z-score
Clean
Earnings quality
4
Forensic signals
-128.1%
ROE
$3.8B
Market cap
Brookdale Senior Living Inc. earns a F (Poor — capital at risk) forensic quality grade, and its Altman Z-score is -2.4, placing it in the Distress zone. 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
0%Return on invested capital.Return on invested capital is 0% and steady — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
+7.8%/yrShare-count dilution.Diluted share count changed +23% over the last 3 years to FY2025 (+7.8%/yr). The count is GROWING — existing holders are being diluted. That's ~7.8% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2022 has been diluted ~23%.
0% of revStock-based comp load.Stock-based compensation ran 0% of revenue and 72% of free cash flow in FY2025 — about $0.05 per diluted share. Heavy — a large slice of 'free cash flow' is really being paid out in stock, so the true owner cash per share is well below the headline.
stoppedShareholder returns — halted.Capital returns have STOPPED — $18M of buybacks + dividends in FY2020, but ~$0 in FY2022. A halt usually means the company is conserving cash; understand why before reading it as neutral.
Key fundamentals
Net Margin-8.2%
Free Cash Flow$16.5M
Latest Revenue$3.19B
Revenue Growth YoY+2.2%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on Brookdale Senior Living Inc.:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about BKD's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown